Full history for every metric is available with a Kvantra account
China Chemical & Pharmaceutical Co., Ltd. (1701.TW)
Key financial summary
Financials in TWD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | TWD m | 7,580 | 7,970 | 8,181 | 7,949 | 8,457 | 8,575 | 8,871 |
| Operating profit | TWD m | 229 | 372 | |||||
| Net profit | TWD m | 370 | 385 | 557 | 518 | 478 | 322 | 355 |
| EPS reported | TWD | 1.08 | 1.19 | |||||
| Operating cashflow per share | TWD | 0.81 | 0.81 | |||||
| Capex per share | TWD | 1.03 | 1.03 | |||||
| FCF per share | TWD | -0.22 | -0.22 | |||||
| Free cash flow | TWD m | -67 | 220 | |||||
| Net debt | TWD m | 2,593 | 2,299 | |||||
| Book value equity | TWD m | 7,432 | 7,402 | |||||
| Book value per share | TWD | 24.89 | 24.82 | |||||
| Number of shares | m | 298.65 | 298.24 | |||||
| DPS (TTM paid) | TWD | 0.80 | 0.50 |
Financial summary
Financials in TWD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 22.55 | - | |||||
| P/B LTM | x | 0.98 | 0.85 | |||||
| P/S LTM | x | 0.85 | 0.71 | |||||
| P/FCF LTM | x | -108.97 | 28.71 | |||||
| EV/EBITDA LTM | x | 18.88 | 11.03 | |||||
| EV/Sales LTM | x | 1.20 | 0.97 | |||||
| Earnings Yield LTM | % | 4.43% | 5.13% | |||||
| FCF Yield | % | -0.92% | 3.48% | |||||
| Quality | ||||||||
| ROE | % | 4.34% | 4.35% | |||||
| ROIC | % | 1.46% | 1.46% | |||||
| Operating margin | % | 2.67% | 2.67% | |||||
| Gross margin | % | 35.44% | 35.44% | |||||
| FCF/Sales | % | -0.78% | -0.78% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -32.08% | -8.46% | |||||
| Sales Growth YoY | % | +1.40% | +3.17% | |||||
| Net Income Growth YoY | % | -32.51% | -8.20% | |||||
| FCF Growth | % | - | -24.94% | |||||
| Operating Profit Growth | % | -63.02% | -26.51% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 3.28% | 2.36% | |||||
| Dividend Growth | % | -11.11% | - | |||||
| Payout Ratio | % | 73.99% | 66.96% | |||||
| FCF/Debt | x | -0.02 | 0.07 | |||||
| Net Debt/EBITDA | x | 5.51 | 5.51 | |||||
| EBIT/Net interest | x | 3.85 | 3.85 | |||||
| Net debt/market cap | % | 35.67% | 36.47% | |||||
| Net debt/Equity | x | 0.35 | 0.31 | |||||
| Gross debt/equity | x | 0.46 | 0.42 | |||||
Company overview
China Chemical & Pharmaceutical Co., Ltd. (CCP), established in Taipei, Taiwan, in 1952, is a prominent player in the pharmaceutical sector. The company specializes in the research, development, manufacturing, and distribution of generic pharmaceutical and healthcare products, serving both human and animal health markets. Its extensive human pharmaceutical portfolio encompasses a wide array of therapeutic areas. Key offerings include medications for cardiovascular health (such as treatments for heart conditions, cholesterol management, and peripheral circulation disorders), metabolic conditions (including diabetes, weight management, and corticosteroid therapies), and infectious diseases (like antibiotics, antifungals, and antivirals). CCP also provides a range of nutritional supplements, from vitamins and hepatic support agents to electrolyte and caloric preparations. Other significant categories cover pain and inflammation relief (antipyretics, analgesics, anti-inflammatories), digestive system remedies (gastrointestinal drugs, gut health enhancers, antispasmodics), and respiratory treatments (antitussives, antihistamines, and asthma medications). Furthermore, the company produces drugs addressing urological issues (specifically for benign prostatic hyperplasia), central nervous system disorders (hypnotics, mood stabilizers, and antidepressants), and critical areas like hematology and oncology, alongside other general preparations and sexual well-being products. Beyond prescription medications, CCP's non-prescription (OTC) division offers popular consumer health products, such as vitamins, topical skincare items, cold and cough remedies, anti-inflammatory pain relievers, and digestive aids. The company additionally supplies antibacterial and disinfectant solutions. In the animal health sector, CCP manufactures veterinary pharmaceuticals catering to livestock (pigs and cattle), poultry, and companion animals, alongside various feed supplements. Rounding out its operations, China Chemical & Pharmaceutical Co., Ltd. offers contract manufacturing services to other industry players.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
China Chemical & Pharmaceutical Co., Ltd. (1701.TW)
China Chemical & Pharmaceutical Co., Ltd. (CCP), established in Taipei, Taiwan, in 1952, is a prominent player in the pharmaceutical sector. The company specializes in the research, development, manufacturing, and distribution of generic pharmaceutical and healthcare products, serving both human and animal health markets. Its extensive human pharmaceutical portfolio encompasses a wide array of therapeutic areas. Key offerings include medications for cardiovascular health (such as treatments for heart conditions, cholesterol management, and peripheral circulation disorders), metabolic conditions (including diabetes, weight management, and corticosteroid therapies), and infectious diseases (like antibiotics, antifungals, and antivirals). CCP also provides a range of nutritional supplements, from vitamins and hepatic support agents to electrolyte and caloric preparations. Other significant categories cover pain and inflammation relief (antipyretics, analgesics, anti-inflammatories), digestive system remedies (gastrointestinal drugs, gut health enhancers, antispasmodics), and respiratory treatments (antitussives, antihistamines, and asthma medications). Furthermore, the company produces drugs addressing urological issues (specifically for benign prostatic hyperplasia), central nervous system disorders (hypnotics, mood stabilizers, and antidepressants), and critical areas like hematology and oncology, alongside other general preparations and sexual well-being products. Beyond prescription medications, CCP's non-prescription (OTC) division offers popular consumer health products, such as vitamins, topical skincare items, cold and cough remedies, anti-inflammatory pain relievers, and digestive aids. The company additionally supplies antibacterial and disinfectant solutions. In the animal health sector, CCP manufactures veterinary pharmaceuticals catering to livestock (pigs and cattle), poultry, and companion animals, alongside various feed supplements. Rounding out its operations, China Chemical & Pharmaceutical Co., Ltd. offers contract manufacturing services to other industry players.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free